ALXN (7/24/11, +50.93%)
GNC (3/18/12, +0.09%)
ULTA (4/8/12, -0.12%)
LQDT (12/25/11, +42.38%)
MA (9/24/11, +30.69%)
MNST (10/16/11, +36.20%)
DG (4/8/12, -1.95%)
NUS (4/15/12, +0.00%)
DLTR (9/4/11, +34.84%)
VRSK (4/8/12, +0.21%)
TJX (3/25/12, +3.08%)
Additions:
NUS (4/15/12, +0.00%)
Subtractions:
None
Last week, all the major U.S. indexes powered lower. The Dow gave up 1.6%, the NYSE composite lost 1.9%, the S&P 500 sank 2.0%, and the Nasdaq dived 2.2%,. The IBD outlook remains at “market in correction”. Down days are coming on higher volume while the few up days are coming on lighter volume, exactly the opposite of what you want to see. The only bright spot, so far, is that the watch list stocks seem to be holding up better than the overall market. That said, it doesn’t pay to fight a plunging tape. Raise cash where appropriate, play portfolio defense, and watch from the sidelines until the next uptrend starts.
With the market in correction, none of the watch list stocks can be considered as buy candidates.
/as usual, your mileage may vary, always do your own homework
Bonus content:
The following stocks currently exhibit potential technical characteristics consistent with historically successful shorting opportunities, emphasis on POTENTIAL:
INCORRECTLY SHORTING STOCKS CAN LEAD TO UNLIMITED LOSSES. Proceed at your own risk.
/How to Make Money Selling Stocks Short by William J. O’Neil
Filed under: Blog Entry | Tagged: IBD, Investing, Investors Business Daily, Stocks, Watch List |
Leave a comment